By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


 

Neuro-Hitech, Inc. 

One Penn Plaza
Suite 1503
New York  New York  10019  U.S.A.
Phone: 212-594-1215 Fax: 212-594-1242


SEARCH JOBS








Company News
Neuro-Hitech, Inc. (NHPI) Announces Modification of Terms of Acquisition of MCR American Pharmaceuticals and AMBI Pharmaceuticals 11/20/2008 10:35:42 AM
Neuro-Hitech, Inc. (NHPI) Announces Acquisition of MCR American Pharmaceuticals 6/11/2008 6:24:25 AM
Neuro-Hitech, Inc. (NHPI) Receives Notice of Delisting from NASDAQ 3/31/2008 12:00:14 PM
Neuro-Hitech, Inc. (NHPI) Receives Delisting Warning Letter from NASDAQ 3/21/2008 8:32:06 AM
Neuro-Hitech, Inc. (NHPI) Announces Agreement with Numoda to Progress Development of Huperzine A in Alzheimer's Disease 3/10/2008 9:14:34 AM
Neuro-Hitech, Inc. (NHPI) Receives Delisting Warning Letter from NASDAQ 2/25/2008 9:22:34 AM
Neuro-Hitech, Inc. (NHPI) Reports Cognitive Improvement From Phase Two Clinical Trial of Huperzine A In Alzheimer's Disease Patients 2/1/2008 9:03:47 AM
Neuro-Hitech, Inc. (NHPI) Announces Completion of Double-Blind Part of Phase Two Clinical Trial of Huperzine A in Alzheimer's Disease 12/14/2007 9:30:49 AM
Neuro-Hitech, Inc. (NHPI) Announces Private Offering of $5.0 Million 11/30/2007 9:24:46 AM
Neuro-Hitech, Inc. (NHPI) Director Terminates Rule 10b5-1 Plan 9/25/2007 1:08:06 PM
123
//-->